Biotech startups in Montréal, Canada
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Kainova Therapeutics | Montréal | Series B | $23.5M | 2026-02-09 |
| Opalia | Montréal | Seed | $2.3M | 2026-04-28 |
| My Intelligent Machines | Montréal | Seed | $5.0M | 2021-04-15 |
| Hippoc | Montréal | Seed | $2.3M | 2023-01-31 |
| Neurenati Therapeutics | Montréal | Seed | $1.7M | 2024-04-18 |
| Innodem Neurosciences | Montréal | Series A | $6.0M | 2021-01-19 |
6 rows of the CSV in 5 of its 18 columns.
- The 42 biotech startups in Montréal, Canada have raised $540.0M in total.
- 7 of them closed their most recent round in the last 12 months, $72.1M combined.
- The largest of those rounds is Kainova Therapeutics' $23.5M Series B, dated February 2026.
- The most recent is Thryv Therapeutics' $21.5M Series B on 3 November 2026.
- Business Development Bank of Canada is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 35 companies (83%).
- 20% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (64% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
2 of 42| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Opalia | Opalia develops cell-based food technology for producing animal-free dairy. | Biotech | Seed | $2.3M | 2026-04-28 | $3.9M | Business Development Bank of Canada, Investissement Quebec, Cycle Momentum +2 | 1 to 10 | 2020 |
| Kainova Therapeutics | Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. | Biotech | Series B | $23.5M | 2026-02-09 | $123.6M | Bpifrance, Sofinnova Partners, Andera Partners +1 | 11 to 50 | 2001 |
Table 1. Biotech startups in Montréal, Canada: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 42.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kainova Therapeutics | Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. | Biotech | Series B | $23.5M | 2026-02-09 | $123.6M | Bpifrance, Sofinnova Partners, Andera Partners +1 | 11 to 50 | 2001 |
| 2 | Opalia | Opalia develops cell-based food technology for producing animal-free dairy. | Biotech | Seed | $2.3M | 2026-04-28 | $3.9M | Business Development Bank of Canada, Investissement Quebec, Cycle Momentum +2 | 1 to 10 | 2020 |
Table 2. Biotech startups in Montréal, Canada: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Business Development Bank of Canada | Private equity firm | Montréal, Canada | 2 | 5% | 1 | Opalia |
| 2 | Investissement Quebec | Fund of funds | Quebec, Canada | 2 | 5% | 1 | Opalia |
| 3 | Anges Quebec | Angel group | Quebec, Canada | 2 | 5% | ||
| 4 | Desjardins Venture Capital | Venture capital firm | Lévis, Canada | 2 | 5% | ||
| 5 | Sofinnova Partners | Venture capital firm | Paris, France | 1 | 2% | 1 | Kainova Therapeutics |
| 6 | adMare Bio Innovations | Startup accelerator | Vancouver, Canada | 1 | 2% | 1 | Kainova Therapeutics |
| 7 | Andera Partners | Private equity firm | Paris, France | 1 | 2% | 1 | Kainova Therapeutics |
| 8 | Bpifrance | Government investment office | Maisons-alfort, France | 1 | 2% | 1 | Kainova Therapeutics |
| 9 | Kale United | Corporate venture arm | Stockholm, Sweden | 1 | 2% | 1 | Opalia |
| 10 | Cycle Momentum | Startup accelerator | Montréal, Canada | 1 | 2% | 1 | Opalia |
| 11 | BoxOne Ventures | Private equity firm | Montréal, Canada | 1 | 2% | 1 | Opalia |
| 12 | AQC Capital | Government investment office | Montréal, Canada | 1 | 2% | ||
| 13 | Real Ventures | Venture capital firm | Montréal, Canada | 1 | 2% | ||
| 14 | Innovacorp | Micro VC fund | Halifax, Canada | 1 | 2% | ||
| 15 | Colvest Holdings | Private equity firm | Montréal, Canada | 1 | 2% |
Table 3. Biotech startups in Montréal, Canada: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 35 | 83% | $469.6M |
| Software | 9 | 21% | $11.9M |
| Artificial intelligence | 5 | 12% | $5.0M |
| Hardware | 1 | 2% | $107K |
Table 4. Biotech startups in Montréal, Canada by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 4 | 10% | $500K |
| Seed | 21 | 50% | $1.0M |
| Series A | 7 | 17% | $11.2M |
| Series B | 5 | 12% | $21.5M |
| Series C | 2 | 5% | $69.3M |
| Series D+ | 3 | 7% | $21.0M |
Table 5. Biotech startups in Montréal, Canada by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 14% | $21.5M |
| July 2026 | 1 | 14% | $100K |
| May 2026 | 1 | 14% | $14.7M |
| April 2026 | 1 | 14% | $2.3M |
| March 2026 | 1 | 14% | |
| February 2026 | 1 | 14% | $23.5M |
| December 2025 | 1 | 14% | $10.0M |
Table 6. Biotech startups in Montréal, Canada: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 6 | 14% | $62.1M |
| 2025 | 3 | 7% | $17.8M |
| 2024 | 3 | 7% | $96.7M |
| 2023 | 4 | 10% | $14.0M |
| 2022 | 3 | 7% | $69.5M |
| 2021 | 3 | 7% | $11.1M |
Table 7. Biotech startups in Montréal, Canada by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 8% |
| 2020 to 2022 | 5 | 12% |
| 2015 to 2019 | 19 | 48% |
| 2010 to 2014 | 3 | 8% |
| Before 2010 | 10 | 25% |
Table 8. Biotech startups in Montréal, Canada by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 27 | 64% |
| 11 to 50 | 13 | 31% |
| 51 to 100 | 2 | 5% |
Table 9. Biotech startups in Montréal, Canada by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Montréal, Canada. On 16 November 2026 that is 42 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 2 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 42 rows: 8 have no round amount, 0 no city and 16 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Montréal, Canada are on the list?
- 42, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 42 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.